Stockreport

MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference

MiNK Therapeutics, Inc.  (INKT) 
PDF NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, [Read more]